Investigating the effect of combined use of selenium and Myo-inositol supplements on thyroid function and autoimmune characteristics in thyroid disorders: a systematic review and meta-analysis

References

• Mikulska AA, Karaźniewicz-Łada M, Filipowicz D, et al. Metabolic characteristics of Hashimoto’s thyroiditis patients and the role of microelements and diet in the disease management—an overview. International Journal of Molecular Sciences. 2022;23(12):6580. doi: 10.3390/ijms23126580
   PubMed Web of Science ®Google Scholar
• Fan Y, Xu S, Zhang H, et al. Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis. Int J Endocrinol. 2014;2014:1–8. doi: 10.1155/2014/904573
   Web of Science ®Google Scholar
• Wichman J, Winther, KH, Bonnema, SJ, et al. Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid: Offic J Am Thyroid Association. 2016;26(12):1681–1692. doi: 10.1089/thy.2016.0256
   PubMed Web of Science ®Google Scholar
• Qiu Y, Xing Z, Xiang Q, et al. Insufficient evidence to support the clinical efficacy of selenium supplementation for patients with chronic autoimmune thyroiditis. Endocrine. 2021;73(2):384–397. doi: 10.1007/s12020-021-02642-z
   PubMed Web of Science ®Google Scholar
• Paparo SR, Ferrari SM, Patrizio A, et al. Myoinositol in autoimmune thyroiditis. Front Endocrinol. 2022;13:930756. doi: 10.3389/fendo.2022.930756
   PubMed Web of Science ®Google Scholar
• Barbaro D, Porcaro G, Benvenga S. Myo-inositol for subclinical hypothyroidism and potential prevention of thyroid tumors. Clin Guide Inositols Elsevier. 2023;213–231.
   Google Scholar
• Grasberger H, Van Sande J, Hag-Dahood Mahameed A, et al. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis. J Clin Endocrinol Metab. 2007;92(7):2816–2820. doi: 10.1210/jc.2007-0366
   PubMed Web of Science ®Google Scholar
• Ohye H, Sugawara M. Dual oxidase, hydrogen peroxide and thyroid diseases. Exp Biol Med. 2010;235(4):424–433. doi: 10.1258/ebm.2009.009241
   Web of Science ®Google Scholar
• Parma J, Van Sande J, Swillens S, et al. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3‘, 5’-monophosphate and inositol phosphate-Ca2+ cascades. Mol Endocrinol. 1995;9(6):725–733. doi: 10.1210/mend.9.6.8592518
   PubMedGoogle Scholar
• Benvenga S, Nordio M, Laganà AS, et al. The role of inositol in thyroid physiology and in subclinical hypothyroidism management. Front Endocrinol. 2021;12:458. doi: 10.3389/fendo.2021.662582
   Web of Science ®Google Scholar
• Nordio M, Basciani S. Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto’s patients with subclinical hypothyroidism. Eur Rev Med Pharmacol Sci. 2017;21(2 Suppl):51–9. doi: 10.1155/2017/2549491
   PubMedGoogle Scholar
• Ferrari S, Elia G, Ragusa F, et al. Myo-inositol and selenium in subclinical hypothyroidism. Int J Med Device Adjuv Treat. 2018;1:e166.
   Google Scholar
• Ferrari S, Fallahi P, Di Bari F, et al. Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis. Eur Rev Med Pharmacol Sci. 2017;21(2 Suppl):36–42.
   PubMedGoogle Scholar
• Pace C, Tumino D, Russo M, et al. Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression. Endocrine J. 2020;67:EJ20–0062.
   Web of Science ®Google Scholar
• Nordio M, Basciani S. Evaluation of thyroid nodule characteristics in subclinical hypothyroid patients under a myo-inositol plus selenium treatment. Eur Rev Med Pharmacol Sci. 2018;22(7):2153–2159. doi: 10.26355/eurrev_201804_14749
   PubMed Web of Science ®Google Scholar
• Porcaro G, Angelozzi P. Myo-inositol and selenium prevent subclinical hypothyroidism during pregnancy: an observational study. IJMDAT. 2018;1(2):e164.
   Google Scholar
• Nordio M, Pajalich R. Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. J Thyroid Res. 2013;2013:1–5. doi: 10.1155/2013/424163
   Google Scholar
• Gartner R, Gasnier BCH, Dietrich JW, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab. 2002;87(4):1687–1691. doi: 10.1210/jcem.87.4.8421
   PubMed Web of Science ®Google Scholar
• Karanikas G, Schuetz M, Kontur S. et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid: Offic J Am Thyroid Association. 2008;18(1):7–12. doi: 10.1089/thy.2007.0127
   PubMed Web of Science ®Google Scholar
• Yan M, Wang S, Miao J, et al. Effect of selenium on the Hashimoto thyroiditis. Chin J Endocrinol Metab. 2008;24(2):194–195.
   Google Scholar
• Zhang W, Wang J, Li J. The effect of selenium on thyroid peroxidase antibody and thyroglobulin antibody in Hashimoto thyroiditis. Med Innov China. 2013;10(14):13–14.
   Google Scholar
• Turker O, Kumanlioglu K, Karapolat I, et al. Selenium treatment in autoimmune thyroiditis: 9-month followup with variable doses. J Endocrinol. 2006;190(1):151. doi: 10.1677/joe.1.06661
   PubMed Web of Science ®Google Scholar
• Duntas LH, Mantzou E, Koutras DA. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol. 2003;148(4):389–393. doi: 10.1530/eje.0.1480389
   PubMed Web of Science ®Google Scholar
• Deng S, Chen X, Wu L. Influence of selenium in Hashimoto thyroiditis with normal thyroid function. Chinese Gen Pract. 2013;70:2483–2485.
   Google Scholar
• Shou L, Ren YZ. Changes of T lymphocyte subsets with selenium treatment on Hashimoto’s thyroiditis, vol. 20, no. 8, pp., 2013. Chin J Integr Med. 2013;20:1241–1242.
   Google Scholar
• Balázs C. The role of hereditary and environmental factors in autoimmune thyroid diseases. orvosi hetilap. Orv Hetil. 2012;153(26):1013–1022. doi: 10.1556/OH.2012.29370
   PubMedGoogle Scholar
• Zhu CY, Deng CZ. Effects of selenium on diffuse toxic goiter autoimmune antibodies. Jilin Medical Journal. 2013;34:3147–3148.
   Google Scholar
• Briguglia G. Time-dependent efficacy of myo-inositol plus selenium in subclinical hypothyroidism. Int J Med Device Adjuv Treat. 2018;1(1):e108.
   Google Scholar